Lv21
128 积分 2021-09-23 加入
Outcomes of First-Line Microwave Ablation of Treatment-Naive Epidermal Growth Factor Receptor–Mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors
4小时前
已完结
Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials
4小时前
已完结
Efficacy and Safety of Dual-Targeted TKIs in ALK-Rearranged, MET-Abberant Advanced NSCLC After Resistance to ALK TKIs
27天前
已关闭
Neoadjuvant therapy for NSCLC: From monotherapy to precision combination therapy
28天前
已完结
Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial
1个月前
已完结
Efficacy and safety of ensartinib in the treatment of non-small cell lung cancer: A systematic review of clinical trials
1个月前
已完结
Too Old for Surgery? A Case Report of an Octogenarian Patient With Locally Advanced Lung Cancer Achieving Long‐Term Survival via Bilobectomy Followed by Adjuvant Targeted Therapy
2个月前
已完结
Sequential EGFR T790M , MET c. 3010C >G‐Associated Exon 14 Alteration, and RET ‐ CCDC6 Fusion in EGFR ‐Mutant NSCLC : A Case Report
2个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
2个月前
已完结
Pulmonary langerhans cell histiocytosis following resection of lung adenocarcinoma: a case report and diagnostic challenges
4个月前
已关闭
皖公网安备34019202002308
